MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
CVRX stock logo

CVRX

CVRx, Inc.

$9.01
-0.09
 (-0.99%)
[ms_data_label text=’Delayed data’]
Exchange:  NASDAQ
Market Cap:  237.068M
Shares Outstanding:  387083
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Kevin Hykes
Full Time Employees:  206
Address: 
9201 West Broadway Avenue
Minneapolis
MN
55445
US
Website:  https://www.cvrx.com
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue39,29551,29256,651
Gross Profit33,03942,95848,340
EBITDA-38,731-54,894-51,265
Operating Income-43,103-59,490-51,265
Net Income-41,199-59,965-53,306

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets115,229133,414104,794
Total Liabilities39,28262,35965,470
Total Stockholders Equity75,94771,05539,324
Total Debt30,61350,43250,790
Cash and Cash Equivalents90,569105,93375,708

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-39,021-39,144-40,170
Capital Expenditure-591-1,361-580
Free Cash Flow-39,612-40,505-40,750
Net Income-41,199-59,965-53,306
Net Change in Cash-15,62515,364-30,225

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)130,375.175Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)136,495.788Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)133,000Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-133,508.541Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-127,521.880Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-130,089.260Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)-32,371.125Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)-30,498.503Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)-31,301.652Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)243,759.728Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)255,203.310Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)248,667.308Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)-1.200Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)-1.170Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)-1.240Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)3Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
51.292M  ?P/S
 (TTM)
: 
3.42
?Net Income
 (TTM)
: 
-59965000  ?P/E
 (TTM)
: 
-3.62
?Enterprise Value
 (TTM)
: 
168.735M  ?EV/FCF
 (TTM)
: 
-4.14
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.99  ?ROIC
 (TTM)
: 
-0.56
?Net Debt
 (TTM)
: 
-55501000  ?Debt/Equity
 (TTM)
: 
1.29
?P/B
 (TTM)
: 
4.91  ?Current Ratio
 (TTM)
: 
7.63

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate CVRX Intrinsic Value

Common questions about CVRX valuation

Is CVRx, Inc. (CVRX) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for CVRx, Inc. (CVRX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is CVRX a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CVRX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is CVRX’s P/E ratio?

You can see CVRX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for CVRX?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is CVRX a good long-term investment?

Whether CVRX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

CVRX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

-0.99
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 4.3   Year High: 12.35
Price Avg 50: 7.5   Price Avg 200: 7.91
Volume: 131385   Average Volume: 318330

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for CVRX

Relevant news

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
27-04-2026 16:30
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
20-04-2026 16:30
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
CVRx, Inc. Investigated by the Portnoy Law Firm
09-04-2026 09:00
CVRx, Inc. Investigated by the Portnoy Law Firm
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
02-03-2026 08:30
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
24-02-2026 17:31
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
19-02-2026 20:06
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read